Short answer
Orthofix Medical Inc. (OFIX) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $211M (up 3.8% year over year) with net income of −$16M.
Q2 2026 key financials · XBRL
- Revenue
- $211M
- +3.8% YoY · +7.2% QoQ
- Net income
- −$16M
- −12.2% YoY · +24.4% QoQ
- Operating margin
- -3.9%
- Gross margin
- 71.0%
- EPS (diluted)
- −$0.38
- −5.6% YoY · +26.9% QoQ
Source: XBRL data from the Orthofix Medical Inc. (OFIX) Q2 2026 10-Q on SEC EDGAR. USD.
Orthofix Medical Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided; supplied text contains Items 2–6 only
- No newly added or materially updated risks identifiable from the provided excerpt
- Executive trading-plan disclosure: up to 1,800 shares through August 31, 2027
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Orthofix Medical Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.